ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

CUSIP: H0036K147

Q2 2021 13F Holders as of 30 Jun 2021

Holder snapshot 7 signals
Share change
+707,041
Put/Call ratio
20%
SEC-reported price per share
$24.35
Number of holders
53
Value change
+$17,173,667
Number of buys
28
Open additional details 1 more signal available
Number of sells
20
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
148,404,655

Security key

H0036K147

Report period

Q2 2021

Institutions

53

Top holders

10

Ownership snapshot

Top reported holders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
31 Mar 2021
13F Highest disclosed value: $189,460,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $189.46M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Disclosed position value Top 5
FMR LLC $189.46M
Redmile Group, LLC $178.4M
JPMORGAN CHASE & CO $76.7M
PRICE T ROWE ASSOCIATES INC /MD/ $67.02M
ALLIANCEBERNSTEIN L.P. $64.21M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
—
denominator unverified
$189,460,000
7,761,585 shares
— 31 Mar 2021
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$178,398,000
7,308,418 shares
— 31 Mar 2021
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$76,702,000
3,142,253 shares
— 31 Mar 2021
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$67,025,000
2,745,794 shares
— 31 Mar 2021
ALLIANCEBERNSTEIN L.P.
13F
Company
13F
—
denominator unverified
$64,210,000
2,630,491 shares
— 31 Mar 2021
Vantage Consulting Group Inc
13F
Company
13F
—
denominator unverified
$41,012,000
1,680,149 shares
— 31 Mar 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
53
Shares
33,533,099
Rows available
53
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
55
Q2 2021 holders
53
Holder diff
-2
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 value Q2 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .